Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for Renal Function in Primary Aldosteronism with CKD After Adrenalectomy
NCT07558811Phase 4Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of hydrocortisone in primary aldosteronism (PA), chronic kidney disease (CKD), sponsored by Ruijin Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
hydrocortisone
03
Conditions
primary aldosteronism (PA)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07558811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07558811.